Spin labels as a tool to identify and characterize protein - Ligand interactions by nmr spectroscopy

ChemBioChem

Volumn 3, Issue 2-3, 2002, Pages 167-173

  Jahnke, Wolfgang ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Drug research; NMR spectroscopy; Protein modifications; Screening; Spin labels

Indexed keywords

NITRO DERIVATIVE; NITROXIDE DERIVATIVE; PROTEIN BCL XL; TRANSITION ELEMENT;

ARTICLE; BINDING AFFINITY; BINDING SITE; DIAGNOSTIC TEST; DIPOLE; DISSOCIATION CONSTANT; DRUG RESEARCH; ELECTRON SPIN RESONANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; ISOTOPE LABELING; LIGAND BINDING; MAGNETIC FIELD; MOLECULAR DYNAMICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEAR OVERHAUSER EFFECT; PHOTOCHEMICAL QUENCHING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SENSITIVITY AND SPECIFICITY; SEQUENCE HOMOLOGY; SPIN LABELING; STRUCTURE ACTIVITY RELATION;

BCL-X PROTEIN; LIGANDS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN CONFORMATION; PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SPIN LABELS; TACROLIMUS BINDING PROTEINS;

EID: 0036523375     PISSN: 14394227     EISSN: None     Source Type: Journal    
DOI: 10.1002/1439-7633(20020301)3:2/3<167::AID-CBIC167>3.0.CO;2-S     Document Type: Article

References (28)

1. S. B. Shuker, P. J. Hajduk, R. P. Meadows, S. W. Fesik, Science 1996, 274, 1531.
2. J. W. Peng, C. A. Lepre, J. Fejzo, N. Abdul-Manan, J. M. Moore, Methods Enzymol. 2001, 338, 202.
3. T. Diercks, M. Coles, H. Kessler, Curr. Opin. Chem. Biol. 2001, 5, 285.
4. M. J. Shapiro, J. R. Wareing, Curr. Opin. Drug Discovery Dev. 1999, 2, 396.
5. W. Jahnke, L. B. Perez, C. G. Paris, A. Strauss, G. Fendrich, C. M. Nalin, J. Am. Chem. Soc. 2000, 122, 7394.
6. W. Jahnke, S. Ruedisser, M. Zurini, J. Am. Chem. Soc. 2001, 123, 3149.
7. R.A. Dwek, Monographs on Physical Biochemistry: Nuclear Magnetic Resonance (N.M.R.) in Biochemistry. Applications to enzyme systems, Oxford University Press, New York, 1973.
8. P. A. Kosen, Methods Enzymol. 1989, 177, 86.
9. P. Jost, O. H. Griffith, Methods Pharmacol. 1972, 2, 223.
10. T. R. Krugh, Spin Labeling 1976, 339.
11. J. A. Peters, J. Huskens, D.J. Raber, Prog. Nucl. Magn. Reson. Spectrosc. 1996, 28, 283.
12. J. R. Tolman, J. M. Flanagan, M.A. Kennedy, J.H. Prestegard, Proc. Nat/Natl. Acad. Sci. USA 1995, 92, 9279.
13. J. H. Prestegard, Nat. Struct. Biol. 1998, 5, 517.
14. N. Tjandra, J. G. Omichinski, A.M. Gronenborn, G. M. Clore, A. Bax, Nat. Struct. Biol. 1997, 4, 732.
15. J. Feeney, B. Birdsall, A. F. Bradbury, R. R. Biekofsky, P. M. Bayley, J. Biomol. NMR 2001, 21, 41.
16. Techniques in Protein Modification (Ed.: R. L. Lundblad), CRC, Boca Raton, FL, 1995.
17. A. Ross, H. Senn, Drug Discovery Today 2001, 6, 583.
18. This Kd value was determined by NMR spectroscopic titration of FKBP with 1.
19. The spin-lock period is used to translate broad lines into less intense lines.
20. G. Thoma, J. L. Magnani, J. T. Patton, B. Ernst, W. Jahnke, Angew. Chem. 2001, 113, 1995; Angew. Chem. Int. Ed. 2001, 40, 1941.
21. G. Thoma, J. L. Magnani, J. T. Patton, B. Ernst, W. Jahnke, Angew. Chem. 2001, 113, 1995; Angew. Chem. Int. Ed. 2001, 40, 1941.
22. M. Mayer, B. Meyer, J. Am. Chem. Soc. 2001, 123, 6108,
23. V. W. Cornish, D. R. Benson, C. A. Altenbach, K. Hideg, W. L. Hubbell, P. G. Schultz, Proc. Natl. Acad, Sci. USA 1994, 91, 2910.
24. T. Imoto, H. Yamada in Protein Function, 2nd ed. (Ed.: T. E. Creighton), IRL, Oxford, 1997, p. 279.
25. L. W. Donaldson, N. R. Skrynnikov, W.-Y. Choy, D. R. Muhandiram, B. Sarkar, J. D. Forman-Kay, L. E. Kay, J. Am. Chem. Soc. 2001, 123, 9843.
26. D. Li, E. F. DeRose, R. E. London, J. Biomol. NMR 1999, 15, 71.
27. R. E. London, J. Magn. Reson. 1999, 741, 301.
28. D. A. Hall, D. C. Maus, G. J. Gerfen, S. Inati, L. R. Becerra, F. W. Dahlquist, R. G. Griffin, Science 1997, 276, 930.